chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Hyperhidrosis, Nausea, Vertigo
Clinical narrative: sweating so bad; vertigo; Dizziness; Nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating so bad), VERTIGO (vertigo), DIZZINESS (Dizziness), NAUSEA (Nausea) and CHILLS (chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001821A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced CHILLS (chills). On 26-Mar-2021, the patient experienced NAUSEA (Nausea). On 27-Mar-2021, the patient experienced HYPERHIDROSIS (sweating so bad), VERTIGO (vertigo) and DIZZINESS (Dizziness). At the time of the report, HYPERHIDROSIS (sweating so bad), DIZZINESS (Dizziness), NAUSEA (Nausea) and CHILLS (chills) outcome was unknown and VERTIGO (vertigo) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient  had a bad vertigo that lasted for 4 days before it tapered off  It was reported that the patient is concerned about getting the 2nd dose  No concomitant medication reported   No treatment medication reported
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Bedridden, Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Can't get out of bed; Aches and pain; Chills; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Can't get out of bed), PAIN (Aches and pain), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pneumonia, Clot blood, COVID-19 and Hospitalization. Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced BEDRIDDEN (Can't get out of bed), PAIN (Aches and pain), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue). At the time of the report, BEDRIDDEN (Can't get out of bed), PAIN (Aches and pain), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information for the patient included Tylenol.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue
Clinical narrative: tightness in the chest; felt tired when she went up the stairs; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tightness in the chest) and FATIGUE (felt tired when she went up the stairs) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse drug reaction (No Medical history reported.).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced CHEST DISCOMFORT (tightness in the chest) and FATIGUE (felt tired when she went up the stairs). On 18-Mar-2021, CHEST DISCOMFORT (tightness in the chest) and FATIGUE (felt tired when she went up the stairs) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: slight rash on her arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (slight rash on her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (slight rash on her arm). At the time of the report, RASH (slight rash on her arm) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use not reported.   Treatment information not reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pharyngitis, Vaccination site pain
Clinical narrative: swollen lymph node on the right side of my neck; a lot of drainage down the back of my throat; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain), LYMPHADENOPATHY (swollen lymph node on the right side of my neck) and PHARYNGITIS (a lot of drainage down the back of my throat) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On 31-Mar-2021, the patient experienced LYMPHADENOPATHY (swollen lymph node on the right side of my neck) and PHARYNGITIS (a lot of drainage down the back of my throat). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain), LYMPHADENOPATHY (swollen lymph node on the right side of my neck) and PHARYNGITIS (a lot of drainage down the back of my throat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching on her left leg; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching on her left leg) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis (anaphylaxis reactions in the past to other substances).    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PRURITUS (itching on her left leg). At the time of the report, PRURITUS (itching on her left leg) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included dphenhydramine
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hypersomnia, Pain in extremity
Clinical narrative: slept all day; fatigue; chills; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), HYPERSOMNIA (slept all day), FATIGUE (fatigue), CHILLS (chills) and HEADACHE (headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 13-Apr-2021, the patient experienced HYPERSOMNIA (slept all day), FATIGUE (fatigue), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm), HYPERSOMNIA (slept all day), FATIGUE (fatigue), CHILLS (chills) and HEADACHE (headache) outcome was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse effect.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported , No treatment medication was reported .   Patient is wondering if she can catch the virus from the vaccine??   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: follow up received on 1-jun-2021 Non significant  information was reported .
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Prenatal screening test, Rash
Clinical narrative: Rash; Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) and RASH (Rash) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     Concurrent medical conditions included Supraventricular tachycardia and Chemical sensitivity (Sensitivity to metoprolol and distolic). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy, ACETYLSALICYLIC ACID (ASPIRIN 81), IRON and OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 29-Aug-2020 and the estimated date of delivery was 03-Jun-2021. On 12-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). On 03-Apr-2021, the patient experienced RASH (Rash). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-seventh week of the pregnancy.  The patient was treated with HYDROCORTISONE for Rash, at an unspecified dose and frequency. On 12-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. At the time of the report, RASH (Rash) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Sep-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Prenatal screening test: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, COVID-19, Chills, Illness, Nasal discomfort
Clinical narrative: positive COVID-19 via testing.; sick; chills; nasal not right; ache all over in the back; aches all over in the back and up/down the legs; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), CHILLS (chills), BACK PAIN (ache all over in the back), PAIN IN EXTREMITY (aches all over in the back and up/down the legs) and COVID-19 (positive COVID-19 via testing.) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0481921A and 039AZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ROSUVASTATIN for Cholesterol, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE (CANDESARTAN HCTZ), METOPROLOL and AMLODIPINE for Hypertension, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) for Vitamin C, MULTI VITAMIN & MINERAL and ASCORBIC ACID, ECHINACEA PURPUREA (ECHINACEA + VITAMINA C VITATECH) for Vitamin supplementation, PROBIOTIC 10 and TURMERIC [CURCUMA LONGA RHIZOME] for an unknown indication.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced BACK PAIN (ache all over in the back) and PAIN IN EXTREMITY (aches all over in the back and up/down the legs). On 16-Mar-2021, the patient experienced NASAL DISCOMFORT (nasal not right). On 11-Apr-2021, the patient experienced ILLNESS (sick) and CHILLS (chills). On an unknown date, the patient experienced COVID-19 (positive COVID-19 via testing.). At the time of the report, ILLNESS (sick) had not resolved and CHILLS (chills), BACK PAIN (ache all over in the back), PAIN IN EXTREMITY (aches all over in the back and up/down the legs), COVID-19 (positive COVID-19 via testing.) and NASAL DISCOMFORT (nasal not right) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    This case was linked to US-MODERNATX, INC.-MOD-2021-074925 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074925:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: positive COVID-19 via testing.; sick; chills; nasal not right; ache all over in the back; aches all over in the back and up/down the legs; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), CHILLS (chills), BACK PAIN (ache all over in the back), PAIN IN EXTREMITY (aches all over in the back and up/down the legs) and COVID-19 (positive COVID-19 via testing.) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0481921A and 039AZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ROSUVASTATIN for Cholesterol, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE (CANDESARTAN HCTZ), METOPROLOL and AMLODIPINE for Hypertension, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) for Vitamin C, MULTI VITAMIN & MINERAL and ASCORBIC ACID, ECHINACEA PURPUREA (ECHINACEA + VITAMINA C VITATECH) for Vitamin supplementation, PROBIOTIC 10 and TURMERIC [CURCUMA LONGA RHIZOME] for an unknown indication.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced BACK PAIN (ache all over in the back) and PAIN IN EXTREMITY (aches all over in the back and up/down the legs). On 16-Mar-2021, the patient experienced NASAL DISCOMFORT (nasal not right). On 11-Apr-2021, the patient experienced ILLNESS (sick) and CHILLS (chills). On an unknown date, the patient experienced COVID-19 (positive COVID-19 via testing.). At the time of the report, ILLNESS (sick) had not resolved and CHILLS (chills), BACK PAIN (ache all over in the back), PAIN IN EXTREMITY (aches all over in the back and up/down the legs), COVID-19 (positive COVID-19 via testing.) and NASAL DISCOMFORT (nasal not right) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    This case was linked to US-MODERNATX, INC.-MOD-2021-074925 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074925:
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Heart rate increased, Pain, Pain in extremity
Clinical narrative: achiness; headache; sore arm; chills; fever; fast heart beat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills), PYREXIA (fever) and HEART RATE INCREASED (fast heart beat) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills), PYREXIA (fever) and HEART RATE INCREASED (fast heart beat). On an unknown date, the patient experienced PAIN (achiness). On 08-Apr-2021, HEART RATE INCREASED (fast heart beat) had resolved. On 09-Apr-2021, HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, PAIN (achiness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Acetaminophen and Water   This case was linked to US-MODERNATX, INC.-MOD-2021-074900 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074900:1st Dose
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: achiness; headache; sore arm; chills; fever; fast heart beat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills), PYREXIA (fever) and HEART RATE INCREASED (fast heart beat) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills), PYREXIA (fever) and HEART RATE INCREASED (fast heart beat). On an unknown date, the patient experienced PAIN (achiness). On 08-Apr-2021, HEART RATE INCREASED (fast heart beat) had resolved. On 09-Apr-2021, HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, PAIN (achiness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Acetaminophen and Water   This case was linked to US-MODERNATX, INC.-MOD-2021-074900 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074900:1st Dose
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Asthenia, Headache, Pyrexia
Clinical narrative: Weakness; Stomach cramps; Severe vomiting; Joint pain; Injection arm (right arm) is very painful; Severe headache; High fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomach cramps), VOMITING (Severe vomiting), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Injection arm (right arm) is very painful) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from February 2020 to March 2020, Lung disorder NOS from February 2020 to March 2020 and Tendon repair. Concurrent medical conditions included Asthma and Oxygen saturation low (currently receiving breathing treatment).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomach cramps), VOMITING (Severe vomiting), ARTHRALGIA (Joint pain), VACCINATION SITE PAIN (Injection arm (right arm) is very painful), HEADACHE (Severe headache) and PYREXIA (High fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomach cramps), VOMITING (Severe vomiting), ARTHRALGIA (Joint pain), VACCINATION SITE PAIN (Injection arm (right arm) is very painful), HEADACHE (Severe headache) and PYREXIA (High fever) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable   This case was linked to MOD-2021-074897 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: Weakness; Stomach cramps; Severe vomiting; Joint pain; Injection arm (right arm) is very painful; Severe headache; High fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomach cramps), VOMITING (Severe vomiting), ARTHRALGIA (Joint pain) and VACCINATION SITE PAIN (Injection arm (right arm) is very painful) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from February 2020 to March 2020, Lung disorder NOS from February 2020 to March 2020 and Tendon repair. Concurrent medical conditions included Asthma and Oxygen saturation low (currently receiving breathing treatment).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomach cramps), VOMITING (Severe vomiting), ARTHRALGIA (Joint pain), VACCINATION SITE PAIN (Injection arm (right arm) is very painful), HEADACHE (Severe headache) and PYREXIA (High fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weakness), ABDOMINAL PAIN UPPER (Stomach cramps), VOMITING (Severe vomiting), ARTHRALGIA (Joint pain), VACCINATION SITE PAIN (Injection arm (right arm) is very painful), HEADACHE (Severe headache) and PYREXIA (High fever) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable   This case was linked to MOD-2021-074897 (Patient Link).
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness postural
Clinical narrative: Dizziness while standing up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS POSTURAL (Dizziness while standing up) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced DIZZINESS POSTURAL (Dizziness while standing up). At the time of the report, DIZZINESS POSTURAL (Dizziness while standing up) outcome was unknown.            Concomitant medications were not reported. No treatment medications was reported.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Headache, Impaired work ability, Pain in extremity
Clinical narrative: arm sore; patient cannot work; redness; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm sore), IMPAIRED WORK ABILITY (patient cannot work), ERYTHEMA (redness) and HEADACHE (headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0117A21A and 011A21A) for COVID-19 vaccination.     Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and ATORVASTATIN for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm sore), IMPAIRED WORK ABILITY (patient cannot work) and ERYTHEMA (redness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (arm sore) and ERYTHEMA (redness) had resolved, IMPAIRED WORK ABILITY (patient cannot work) outcome was unknown and HEADACHE (headache) had not resolved.            Concomitant medication included prazole for blood pressure was noted.   It was noted that the patient went to the ER (emergency room) because they could not work. The ER advised that the patient take Tylenol for treatment.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Was unable to get her second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Was unable to get her second vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Was unable to get her second vaccine). On 18-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Was unable to get her second vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Medical history and concomitant was not provided.   She was scheduled for the second vaccine for March 18, 2021, but was hospitalized for a colon issue and was unable to get her second vaccine.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy every day/ lightheadedness every day; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy every day/ lightheadedness every day) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease, Thyroid cancer (Removed Thyroid), Lupus anticoagulant, Menopause, Sleep disorder and Syncope vasovagal (all life). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN LOW) for Anticoagulant therapy, LEVOTHYROXINE SODIUM (SYNTHROID) for Hashimoto's disease and Thyroid cancer, AMITRIPTYLINE HYDROCHLORIDE (ELAVIL [AMITRIPTYLINE HYDROCHLORIDE]) for Sleep disorder, MAGNESIUM and VITAMIN D NOS for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced DIZZINESS (Dizzy every day/ lightheadedness every day). The patient was treated with ALPRAZOLAM (XANAX) ongoing since an unknown date for Adverse event, at a dose of 1 dosage form,(taken 2-3 times). At the time of the report, DIZZINESS (Dizzy every day/ lightheadedness every day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient had seen all their regular doctors including a syncope cardiologist. The patient received her second dose of vaccine on 02-Feb-2021.   This case was linked to MOD-2021-074949 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included Surgery.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced DIZZINESS (dizzy). On 19-Mar-2021, DIZZINESS (dizzy) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       She is scheduled for her second dose of vaccine no treatment medication was reported. no concomitant medication was reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dyskinesia, Fatigue, Headache, Influenza like illness, Lymphadenopathy
Clinical narrative: Rash like hives, right eye shut , lips swollen; Rash like hives, right eye shut , lips swollen; Rash under left arm; Swelling of lymph nodes in both armpits; Rash hot to touch; Headache; Flu like symptoms; Rash behind Knee, size of golf ball and bumpy,Rash pretty bad on stomach and back,rash first on upper part of body extending lower part of body.; Tired feeling; Itching and soreness all over body; Itching and soreness all over body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash behind Knee, size of golf ball and bumpy,Rash pretty bad on stomach and back,rash first on upper part of body extending lower part of body.), FATIGUE (Tired feeling), PRURITUS (Itching and soreness all over body), PAIN (Itching and soreness all over body) and URTICARIA (Rash like hives, right eye shut , lips swollen) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced RASH (Rash behind Knee, size of golf ball and bumpy,Rash pretty bad on stomach and back,rash first on upper part of body extending lower part of body.), FATIGUE (Tired feeling), PRURITUS (Itching and soreness all over body) and PAIN (Itching and soreness all over body). On 28-Mar-2021, the patient experienced URTICARIA (Rash like hives, right eye shut , lips swollen), DYSKINESIA (Rash like hives, right eye shut , lips swollen), RASH (Rash under left arm), LYMPHADENOPATHY (Swelling of lymph nodes in both armpits), VACCINATION SITE WARMTH (Rash hot to touch), HEADACHE (Headache) and INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, RASH (Rash behind Knee, size of golf ball and bumpy,Rash pretty bad on stomach and back,rash first on upper part of body extending lower part of body.) and RASH (Rash under left arm) was resolving and FATIGUE (Tired feeling), PRURITUS (Itching and soreness all over body), PAIN (Itching and soreness all over body), URTICARIA (Rash like hives, right eye shut , lips swollen), DYSKINESIA (Rash like hives, right eye shut , lips swollen), LYMPHADENOPATHY (Swelling of lymph nodes in both armpits), VACCINATION SITE WARMTH (Rash hot to touch), HEADACHE (Headache) and INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided by the reporter.  The patient's treatment medications included: Zyrtec, Benadryl ,Prednisone, and Tylenol.  Upon internal review on 04-AUG-2021, the age was corrected to 29 years.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Rash, Urticaria, Vaccination site warmth
Clinical narrative: Rash like hives, right eye shut , lips swollen; Rash like hives, right eye shut , lips swollen; Rash under left arm; Swelling of lymph nodes in both armpits; Rash hot to touch; Headache; Flu like symptoms; Rash behind Knee, size of golf ball and bumpy,Rash pretty bad on stomach and back,rash first on upper part of body extending lower part of body.; Tired feeling; Itching and soreness all over body; Itching and soreness all over body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash behind Knee, size of golf ball and bumpy,Rash pretty bad on stomach and back,rash first on upper part of body extending lower part of body.), FATIGUE (Tired feeling), PRURITUS (Itching and soreness all over body), PAIN (Itching and soreness all over body) and URTICARIA (Rash like hives, right eye shut , lips swollen) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced RASH (Rash behind Knee, size of golf ball and bumpy,Rash pretty bad on stomach and back,rash first on upper part of body extending lower part of body.), FATIGUE (Tired feeling), PRURITUS (Itching and soreness all over body) and PAIN (Itching and soreness all over body). On 28-Mar-2021, the patient experienced URTICARIA (Rash like hives, right eye shut , lips swollen), DYSKINESIA (Rash like hives, right eye shut , lips swollen), RASH (Rash under left arm), LYMPHADENOPATHY (Swelling of lymph nodes in both armpits), VACCINATION SITE WARMTH (Rash hot to touch), HEADACHE (Headache) and INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, RASH (Rash behind Knee, size of golf ball and bumpy,Rash pretty bad on stomach and back,rash first on upper part of body extending lower part of body.) and RASH (Rash under left arm) was resolving and FATIGUE (Tired feeling), PRURITUS (Itching and soreness all over body), PAIN (Itching and soreness all over body), URTICARIA (Rash like hives, right eye shut , lips swollen), DYSKINESIA (Rash like hives, right eye shut , lips swollen), LYMPHADENOPATHY (Swelling of lymph nodes in both armpits), VACCINATION SITE WARMTH (Rash hot to touch), HEADACHE (Headache) and INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided by the reporter.  The patient's treatment medications included: Zyrtec, Benadryl ,Prednisone, and Tylenol.  Upon internal review on 04-AUG-2021, the age was corrected to 29 years.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling of body temperature change, Gait disturbance, Headache
Clinical narrative: mostly tired; sweats; unable to walk properly; hot and cold waves; very sick feeling; sleepy; dizziness; headaches; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), GAIT DISTURBANCE (unable to walk properly), FEELING OF BODY TEMPERATURE CHANGE (hot and cold waves), MALAISE (very sick feeling) and SOMNOLENCE (sleepy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), MULTIVITAMINS [VITAMINS NOS], OMEPRAZOLE and GABAPENTIN for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced HYPERHIDROSIS (sweats), GAIT DISTURBANCE (unable to walk properly), FEELING OF BODY TEMPERATURE CHANGE (hot and cold waves), MALAISE (very sick feeling), SOMNOLENCE (sleepy), DIZZINESS (dizziness) and HEADACHE (headaches). 07-Apr-2021, the patient experienced NAUSEA (nauseous). On 08-Apr-2021, the patient experienced FATIGUE (mostly tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Apr-2021, GAIT DISTURBANCE (unable to walk properly), FEELING OF BODY TEMPERATURE CHANGE (hot and cold waves), MALAISE (very sick feeling), SOMNOLENCE (sleepy) and NAUSEA (nauseous) had resolved. At the time of the report, HYPERHIDROSIS (sweats), HEADACHE (headaches) and FATIGUE (mostly tired) was resolving and DIZZINESS (dizziness) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Patient's demographic  and event dates updated and new events added (Nausea, feeling hot & cold, somnolence, fatigue).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Malaise, Nausea, Somnolence
Clinical narrative: mostly tired; sweats; unable to walk properly; hot and cold waves; very sick feeling; sleepy; dizziness; headaches; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), GAIT DISTURBANCE (unable to walk properly), FEELING OF BODY TEMPERATURE CHANGE (hot and cold waves), MALAISE (very sick feeling) and SOMNOLENCE (sleepy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), MULTIVITAMINS [VITAMINS NOS], OMEPRAZOLE and GABAPENTIN for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced HYPERHIDROSIS (sweats), GAIT DISTURBANCE (unable to walk properly), FEELING OF BODY TEMPERATURE CHANGE (hot and cold waves), MALAISE (very sick feeling), SOMNOLENCE (sleepy), DIZZINESS (dizziness) and HEADACHE (headaches). 07-Apr-2021, the patient experienced NAUSEA (nauseous). On 08-Apr-2021, the patient experienced FATIGUE (mostly tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Apr-2021, GAIT DISTURBANCE (unable to walk properly), FEELING OF BODY TEMPERATURE CHANGE (hot and cold waves), MALAISE (very sick feeling), SOMNOLENCE (sleepy) and NAUSEA (nauseous) had resolved. At the time of the report, HYPERHIDROSIS (sweats), HEADACHE (headaches) and FATIGUE (mostly tired) was resolving and DIZZINESS (dizziness) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Patient's demographic  and event dates updated and new events added (Nausea, feeling hot & cold, somnolence, fatigue).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A, and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY. At the time of the report, PAIN IN EXTREMITY had not resolved.            Concomitant medications included thyroid and blood pressure pills.  Action taken with response to the events are not applicable   This case was linked to MOD-2021-071176. Sender's Comments: MOD-2021-071176: 1st dose of vaccine.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: arm was very tender; arm a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was very tender) and PAIN IN EXTREMITY (arm a little sore) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm was very tender) and PAIN IN EXTREMITY (arm a little sore). At the time of the report, VACCINATION SITE PAIN (arm was very tender) and PAIN IN EXTREMITY (arm a little sore) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.
Sex: F
Vaccine: COVID19
Symptoms: Skin reaction, Vaccination site cellulitis, Vaccination site reaction
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE CELLULITIS (cellulitis), SKIN REACTION (delayed reaction) and VACCINATION SITE REACTION (covid arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE CELLULITIS (cellulitis), SKIN REACTION (delayed reaction) and VACCINATION SITE REACTION (covid arm). At the time of the report, VACCINATION SITE CELLULITIS (cellulitis), SKIN REACTION (delayed reaction) and VACCINATION SITE REACTION (covid arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment drugs were reported
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (I can't taste anything) and VACCINATION SITE PAIN (pain and tenderness in my arm where they gave me the injection) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced AGEUSIA (I can't taste anything) and VACCINATION SITE PAIN (pain and tenderness in my arm where they gave me the injection). At the time of the report, AGEUSIA (I can't taste anything) and VACCINATION SITE PAIN (pain and tenderness in my arm where they gave me the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant and treatment product was reported For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product dose omission issue
Clinical narrative: it has been too long since my first dose of the vaccine; it has been too long since my first dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (it has been too long since my first dose of the vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (it has been too long since my first dose of the vaccine) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (it has been too long since my first dose of the vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (it has been too long since my first dose of the vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (it has been too long since my first dose of the vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (it has been too long since my first dose of the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Injection site mass, Pyrexia, Swelling
Clinical narrative: near my collar bone/neck which is near the injection site, I have a lump; Fever; Chills; swelling; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (near my collar bone/neck which is near the injection site, I have a lump), SWELLING (swelling), PYREXIA (Fever) and CHILLS (Chills) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced SWELLING (swelling). On an unknown date, the patient experienced INJECTION SITE MASS (near my collar bone/neck which is near the injection site, I have a lump), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, INJECTION SITE MASS (near my collar bone/neck which is near the injection site, I have a lump), SWELLING (swelling), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. Concomitant medications were not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested positive for Covid-19; This spontaneous case was reported by a physician and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid-19) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid-19). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.